Hims & Hers obtains YourBio's microsampling tech, which the firm said will speed its efforts to improve blood collection, including outside traditional clinical settings.
Lake Erie sees reduced nutrient runoff and signs of recovery, but climate change and emerging threats continue to challenge ...
Idaho National Laboratory (INL) has selected the five commercial teams that will potentially demonstrate advanced ...
Jacobs, Affiliated Engineers Inc., Burns & McDonnell, EXP, Vanderweil Engineers, Salas O'Brien, WSP, Arup US, and IMEG top ...
TORONTO, Dec. 3, 2025 /PRNewswire/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all ...
Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting ...
Energy-efficient filtration solutions that reduce hidden chemical exposure from benchtop work and lab equipment to improve ...
Registration details for the webinar are as follows: Tuesday, December 2, 2025 - 8:00 am ET The presentation slides and a link to the live and archived webcast will also be available on the Events & ...
Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...
Summary • ProPhase Labs (PRPH) saw a 15% pre-market increase to $0.2406 following a webinar announcement.• The company ...
Summary • ProPhase Labs (PRPH) stock rises 7.7% in pre-market to $0.1950 following an investor webinar announcement.• The ...
You’ve got a great idea for a product, but can you prove that it’s safe and ready for the market? The latest Aqua Agenda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback